Vascular Perfusion Solutions
Pre-clinicalThe VP.S ENCORE® is a premarket cardiac perfusion system designed to extend donor heart viability up to 8 hours.
Founded
2018
Focus
CardiovascularMedical Devices
About
The VP.S ENCORE® is a premarket cardiac perfusion system designed to extend donor heart viability up to 8 hours.
Company Info
TypePrivate
Founded2018
LocationSan Diego, United States
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile